NASDAQ: INCR
Intercure Ltd Stock Ownership - Who owns Intercure?

Insider buying vs selling

Have Intercure Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when INCR insiders and whales buy or sell their stock.

INCR Shareholders

What type of owners hold Intercure Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ibex Investors LLC4.14%1,886,274$2.81MInstitution
Healthcare Of Ontario Pension Plan Trust Fund0.47%212,500$316.63kInstitution
Advisorshares Investments LLC0.24%108,044$160.99kInstitution
Moore Capital Management LP0.21%97,273$144.94kInstitution
Renaissance Technologies LLC0.11%48,300$71.97kInstitution
Citadel Advisors LLC0.09%42,150$62.80kInstitution
Jane Street Group LLC0.06%27,901$41.57kInstitution
Blackrock Inc0.05%24,162$36.00kInstitution
Geode Capital Management LLC0.05%22,539$33.58kInstitution
Squarepoint Ops LLC0.03%11,434$17.04kInstitution

1 of 2

INCR vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INCR5.50%0.00%
ASRT29.16%20.87%Net BuyingNet Selling
CPIX13.19%59.74%Net BuyingNet Selling
CRDL10.66%0.00%
BGM0.06%0.00%

Intercure Stock Ownership FAQ

Who owns Intercure?

Intercure (NASDAQ: INCR) is owned by 5.50% institutional shareholders, 0.00% Intercure insiders, and 94.50% retail investors. Ibex Investors LLC is the largest individual Intercure shareholder, owning 1.89M shares representing 4.14% of the company. Ibex Investors LLC's Intercure shares are currently valued at $2.81M.

If you're new to stock investing, here's how to buy Intercure stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.